Woodstock Corp Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)


Share on StockTwits

Woodstock Corp decreased its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.2% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 92,799 shares of the company’s stock after selling 174 shares during the quarter. Johnson & Johnson makes up about 1.9% of Woodstock Corp’s investment portfolio, making the stock its 11th largest position. Woodstock Corp’s holdings in Johnson & Johnson were worth $15,252,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Trust Asset Management LLC raised its stake in Johnson & Johnson by 80.5% during the third quarter. Trust Asset Management LLC now owns 13,363 shares of the company’s stock worth $1,989,000 after purchasing an additional 5,960 shares during the period. Polar Capital LLP grew its position in Johnson & Johnson by 657.6% in the third quarter. Polar Capital LLP now owns 1,207,177 shares of the company’s stock worth $179,725,000 after acquiring an additional 1,047,825 shares during the period. OLD Mission Capital LLC acquired a new stake in Johnson & Johnson during the third quarter worth $362,000. Global Trust Asset Management LLC grew its holdings in shares of Johnson & Johnson by 3.1% during the 3rd quarter. Global Trust Asset Management LLC now owns 5,504 shares of the company’s stock worth $811,000 after purchasing an additional 166 shares during the period. Finally, Te Ahumairangi Investment Management Ltd acquired a new stake in shares of Johnson & Johnson during the 3rd quarter worth about $5,694,000. 67.25% of the stock is currently owned by institutional investors.

NYSE JNJ traded up $0.25 during trading on Thursday, reaching $163.86. 42,300 shares of the company’s stock were exchanged, compared to its average volume of 8,177,090. The company has a 50 day moving average price of $161.06 and a two-hundred day moving average price of $154.38. The stock has a market cap of $431.40 billion, a P/E ratio of 25.76, a price-to-earnings-growth ratio of 3.06 and a beta of 0.70. Johnson & Johnson has a 1 year low of $133.65 and a 1 year high of $173.65. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.48.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Monday, January 25th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.82 by $0.04. The firm had revenue of $22.50 million during the quarter, compared to analysts’ expectations of $21.62 billion. Johnson & Johnson had a return on equity of 34.64% and a net margin of 21.01%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.88 earnings per share. Research analysts forecast that Johnson & Johnson will post 7.99 EPS for the current fiscal year.

JNJ has been the subject of several research analyst reports. Credit Suisse Group increased their target price on shares of Johnson & Johnson from $168.00 to $193.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 27th. Cantor Fitzgerald increased their price objective on shares of Johnson & Johnson from $180.00 to $200.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 26th. Wells Fargo & Company raised their price target on Johnson & Johnson from $175.00 to $190.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 27th. JPMorgan Chase & Co. boosted their price objective on Johnson & Johnson from $157.00 to $175.00 and gave the company a “neutral” rating in a report on Wednesday, January 27th. Finally, Raymond James increased their price target on shares of Johnson & Johnson from $158.00 to $183.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $178.60.

Johnson & Johnson Profile

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.

Featured Article: Stochastic Momentum Index (SMI)

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.